Search clinical trials for: Placebo for dapagliflozin
Total 70333 results
-
Qingdao Central HospitalRecruitingThe Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial InfarctionMyocardial Infarction | Glucose Intolerance | Diabete Type 2China
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Preserved Systolic FunctionUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
Maastricht UniversityAstraZenecaCompletedPrediabetic State | Substrate OxidationNetherlands
-
Klinikum NürnbergRecruitingChronic Renal Failure | Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte HomeostatisGermany, France
-
Janssen-Cilag International NVCompleted
-
Materia Medica HoldingCompletedAcute Upper Respiratory InfectionsRussian Federation
-
Rehab WeridaUniversity of AlexandriaRecruitingType 2 Diabetes | Nonalcoholic Fatty Liver DiseaseEgypt
-
Saint Luke's Health SystemCompletedChronic Heart Failure With Reduced Systolic FunctionUnited States
-
AstraZenecaRecruitingChronic Kidney Disease and HypertensionSpain, United States, Argentina, Denmark, Italy, Sweden, United Kingdom, Belgium, France, Turkey, China, Germany, Saudi Arabia, Thailand, Vietnam, Australia, Serbia, Brazil, Canada, Japan, Malaysia, Philippines, Poland, Taiwan, Greece, Is... and more
-
University Health Network, TorontoRecruitingType 2 Diabetes | Kidney Transplant Recipients | Post-transplant Diabetes MellitusCanada
-
Sichuan Academy of Medical SciencesRecruitingPeritoneal Dialysis Complication | Renal Function Aggravated | Sodium-glucose Co-transporter-2 InhibitorsChina
-
University of Texas Southwestern Medical CenterNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedObesity, VisceralUnited States
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
Post Graduate Institute of Medical Education and...Not yet recruitingNon-Alcoholic Fatty Liver Disease | Hepatic Steato-FibrosisIndia
-
The University of Hong KongResearch Grant CouncilRecruitingCirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 InhibitorsHong Kong
-
AstraZenecaTerminatedType 2 Diabetes MellitusThailand, Vietnam
-
G.Gennimatas General Hospital2nd Department of Cardiology, "Attikon" University Hospital, National and...Not yet recruitingAcute Kidney Injury | Percutaneous Coronary Intervention | Left Cardiac Catheterization | Sodium-glucose Co-transporter 2 InhibitorsGreece
-
University of WashingtonAstraZenecaCompletedMyocardial Fibrosis | Type 2 Diabetes Mellitus | Myocardial InflammationUnited States
-
Hospices Civils de LyonWithdrawnEnd-stage Heart FailureFrance
-
University of VirginiaRecruitingMyocardial IschemiaUnited States
-
Anita SarafThe Pittsburgh FoundationNot yet recruitingHeart Failure | Adult Congenital Heart DiseaseUnited States
-
Beijing Anzhen HospitalNot yet recruitingAtrial FibrillationChina
-
Mansoura UniversityActive, not recruitingLupus Nephritis | SLE | SGLT2 InhibitorsEgypt
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes Mellitus | Inadequate Glycaemic Control | High HbA1c LevelCzech Republic, Poland, Spain, Germany, Canada, Slovakia
-
AstraZenecaAstra Zeneca, Bristol-Myers SquibbCompletedType 1 Diabetes MellitusUnited States
-
EMSNot yet recruiting
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, Brazil
-
National Medical Research Center for Cardiology...RecruitingHeart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure With Mid Range Ejection Fraction | Amyloid CardiomyopathyRussian Federation
-
Medical University of ViennaRecruitingReperfusion Injury | Vascular ComplicationsAustria
-
October 6 UniversityCairo University; National Heart Institute, EgyptCompletedDiabetes Mellitus | Chronic Heart Failure | Acute Heart FailureEgypt
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
-
LG ChemUnknown
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2United States
-
University of RochesterAstraZenecaCompleted
-
Mansoura UniversityActive, not recruitingLupus Nephritis | BMD | SGLT2 INHIBITORSEgypt
-
AstraZenecaParexel; PRA Health Sciences; Q2 Solutions; Covance Laboratories, IncCompletedType 2 DiabetesUnited States, Israel, Hungary, Russian Federation, Mexico, Romania, United Kingdom
-
LM Diagnósticos S.L.AstraZenecaUnknown
-
The University of Texas Health Science Center at...Janssen Scientific Affairs, LLCWithdrawnCardiovascular Diseases | Type2 Diabetes MellitusUnited States
-
University of Colorado, DenverRecruitingVascular Diseases | Diabetes | Kidney Transplant; ComplicationsUnited States
-
University of OklahomaRecruitingDiabetes Mellitus | Atrial FibrillationUnited States
-
Andrea GiaccariRecruitingType2 Diabetes Mellitus | Stable Coronary Artery DiseaseItaly
-
University of PennsylvaniaAmgenCompleted
-
Mansoura UniversityCompletedAcute Heart FailureEgypt
-
Yonsei UniversityCompletedType 2 Diabetes MellitusKorea, Republic of
-
AstraZenecaBristol-Myers SquibbCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan
-
University Medical Center GroningenAstraZenecaEnrolling by invitationChronic Kidney DiseasesNetherlands, Canada, United States, Denmark, United Kingdom